|
WO2000073454A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001016318A2
(en)
*
|
1999-09-01 |
2001-03-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000075327A1
(en)
*
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
JP2001522239A
(en)
|
1997-03-21 |
2001-11-13 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
87 human secreted proteins
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030059780A1
(en)
*
|
1997-06-16 |
2003-03-27 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7160985B2
(en)
*
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
|
US7425613B2
(en)
|
1997-11-05 |
2008-09-16 |
Genentech, Inc. |
PRO1375 polypeptides
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6949339B1
(en)
|
1998-05-21 |
2005-09-27 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging colon cancer
|
|
US6623923B1
(en)
|
1998-12-23 |
2003-09-23 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US6914130B2
(en)
|
1998-06-17 |
2005-07-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US7291712B2
(en)
|
1998-06-25 |
2007-11-06 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US7507557B2
(en)
|
1998-08-17 |
2009-03-24 |
Genentech, Inc. |
Nucleic acids encoding PRO1375 polypeptides
|
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
PT1109937E
(en)
|
1998-09-02 |
2009-02-10 |
Diadexus Inc |
Method of diagnosing, monitoring, staging, and imaging various cancers
|
|
EP1111046A4
(en)
*
|
1998-09-03 |
2003-07-02 |
Takeda Chemical Industries Ltd |
Novel protein and process for producing the same
|
|
US7014996B1
(en)
|
1998-10-02 |
2006-03-21 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
|
|
EP1131430B1
(en)
|
1998-11-10 |
2007-01-17 |
Emory University |
Mitogenic regulators
|
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US7888477B2
(en)
|
1998-12-17 |
2011-02-15 |
Corixa Corporation |
Ovarian cancer-associated antibodies and kits
|
|
AU2007216683B2
(en)
*
|
1998-12-17 |
2011-07-14 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US20020119158A1
(en)
*
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6670463B1
(en)
|
1998-12-17 |
2003-12-30 |
Corixa Corporation |
Compositions and methods for therapy of ovarian cancer
|
|
US6962980B2
(en)
*
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
JP2002533082A
(en)
*
|
1998-12-23 |
2002-10-08 |
コリクサ コーポレイション |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US6284241B1
(en)
|
1998-12-23 |
2001-09-04 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US20030190669A1
(en)
*
|
1998-12-30 |
2003-10-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1164142A1
(en)
*
|
1999-03-15 |
2001-12-19 |
Takeda Chemical Industries, Ltd. |
Novel proteins and uses thereof
|
|
US6797271B2
(en)
|
1999-03-25 |
2004-09-28 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
US6242419B1
(en)
|
1999-03-25 |
2001-06-05 |
Genesis Research & Development Corporation Ltd. |
Compositions isolated from stromal cells and methods for their use
|
|
WO2000061754A2
(en)
*
|
1999-04-09 |
2000-10-19 |
Curagen Corporation |
Human proteins and polynucleotides encoding them
|
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
EP1792989A1
(en)
*
|
1999-04-12 |
2007-06-06 |
Agensys, Inc. |
13 Transmembrane protein expressed in prostate cancer
|
|
US7244827B2
(en)
|
2000-04-12 |
2007-07-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
IL145775A0
(en)
*
|
1999-04-12 |
2002-07-25 |
Agensys Inc |
13 transmembrane protein expressed in prostate cancer
|
|
AU779787B2
(en)
*
|
1999-05-14 |
2005-02-10 |
Curagen Corporation |
Secreted polypeptides and corresponding polynucleotides
|
|
WO2000071581A1
(en)
*
|
1999-05-20 |
2000-11-30 |
Takeda Chemical Industries, Ltd. |
Novel polypeptide
|
|
AU5037100A
(en)
*
|
1999-05-27 |
2000-12-18 |
Zymogenetics Inc. |
Adipocyte complement related protein homolog zacrp6
|
|
ATE449174T1
(en)
|
1999-07-23 |
2009-12-15 |
Kenji Kangawa |
NEW PEPTIDES
|
|
AU6181600A
(en)
*
|
1999-07-29 |
2001-02-19 |
Helix Research Institute |
Guanosine triphosphate-binding protein coupled receptors, genes thereof and production and use of the same
|
|
WO2001010902A2
(en)
*
|
1999-08-11 |
2001-02-15 |
Curagen Corporation |
Nucleoc acids and secreted polypeptides encoded thereby
|
|
CA2381794A1
(en)
*
|
1999-08-18 |
2001-02-22 |
Zymogenetics, Inc. |
Helical cytokine zalpha48
|
|
EP1621620A3
(en)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU7377300A
(en)
*
|
1999-09-13 |
2001-04-17 |
Curagen Corporation |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
EP1220919A2
(en)
*
|
1999-09-29 |
2002-07-10 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Metastasis-associated antigen c4.4a
|
|
DE19947010A1
(en)
*
|
1999-09-30 |
2001-04-05 |
Universitaetsklinikum Freiburg |
The PRV-1 gene and its use
|
|
GB9926532D0
(en)
*
|
1999-11-09 |
2000-01-12 |
Smithkline Beecham Biolog |
Novel compounds
|
|
AU1485301A
(en)
*
|
1999-11-12 |
2001-06-06 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same
|
|
WO2001036465A2
(en)
*
|
1999-11-16 |
2001-05-25 |
Zymogenetics, Inc. |
Human zven proteins
|
|
US6485938B1
(en)
|
1999-11-16 |
2002-11-26 |
Zymogenetics, Inc. |
Nucleic acid molecules that encodes human Zven1
|
|
AU2067601A
(en)
*
|
1999-12-09 |
2001-06-18 |
Zymogenetics Inc. |
Zvwf1: a member of the von willebrand factor type a domain superfamily
|
|
AU2575601A
(en)
*
|
1999-12-10 |
2001-06-18 |
Incyte Genomics, Inc. |
Extracellular matrix and cell adhesion molecules
|
|
WO2001049716A2
(en)
*
|
1999-12-30 |
2001-07-12 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
JP4280444B2
(en)
*
|
2000-01-06 |
2009-06-17 |
ジェネンテック・インコーポレーテッド |
Compositions and methods for inhibiting neoplastic cell growth
|
|
EP1252298A2
(en)
*
|
2000-01-28 |
2002-10-30 |
Incyte Genomics, Inc. |
Phosphodiesterases
|
|
WO2001064856A2
(en)
*
|
2000-02-28 |
2001-09-07 |
The Government Of The United States Of America, A S Represented By The Secretary, Department Of Hea Lth And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1268793A2
(en)
|
2000-03-22 |
2003-01-02 |
Amgen, Inc. |
Fibroblast growth factor receptor-like molecules and uses thereof
|
|
EP1278858A2
(en)
*
|
2000-03-24 |
2003-01-29 |
Millennium Pharmaceuticals, Inc. |
46743 and 27417, novel human acyltransferase family members and uses therefor
|
|
AU4884001A
(en)
|
2000-04-21 |
2001-11-07 |
Fuso Pharmaceutical Ind |
Novel collectins
|
|
JP2007274956A
(en)
*
|
2006-04-05 |
2007-10-25 |
Fuso Pharmaceutical Industries Ltd |
hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
|
|
CA2407746A1
(en)
*
|
2000-05-04 |
2001-11-08 |
Incyte Genomics, Inc. |
Proteases
|
|
US6444443B1
(en)
*
|
2000-05-19 |
2002-09-03 |
Novartis Ag |
Gene
|
|
JP2004514651A
(en)
|
2000-05-30 |
2004-05-20 |
メルク エンド カムパニー インコーポレーテッド |
Ghrelin analogs
|
|
KR20100029069A
(en)
*
|
2000-06-23 |
2010-03-15 |
제넨테크, 인크. |
Eg-vegf nucleic acids and polypeptides and methods of use
|
|
US20020165347A1
(en)
*
|
2000-06-30 |
2002-11-07 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
WO2002006483A1
(en)
*
|
2000-07-18 |
2002-01-24 |
Takeda Chemical Industries, Ltd. |
Novel physiologically active peptide and use thereof
|
|
JP4965776B2
(en)
*
|
2000-07-18 |
2012-07-04 |
武田薬品工業株式会社 |
Novel bioactive peptides and uses thereof
|
|
WO2002010187A1
(en)
|
2000-07-27 |
2002-02-07 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
|
WO2002016581A2
(en)
*
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
AU2002216610A1
(en)
*
|
2000-09-01 |
2002-04-02 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU2002230736A1
(en)
*
|
2000-10-30 |
2002-05-15 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
EP1506971A1
(en)
*
|
2000-11-03 |
2005-02-16 |
The Regents of the University of California |
Prokineticin polypeptides, related compositions and methods
|
|
MXPA03003902A
(en)
*
|
2000-11-03 |
2004-04-02 |
Univ California |
Prokineticin polypeptides, related compositions and methods.
|
|
WO2002052019A2
(en)
*
|
2000-12-21 |
2002-07-04 |
Millennium Pharmaceuticals, Inc. |
22437, a human sulfatase and uses therefor
|
|
US20060063230A1
(en)
|
2000-12-27 |
2006-03-23 |
Roman Naworth |
Sulfatases and methods of use thereof
|
|
WO2002062996A1
(en)
*
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Novel physiologically active peptide and use thereof
|
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
AU2002304826A1
(en)
*
|
2001-03-01 |
2002-10-08 |
Lion Bioscience Ag |
Cofactors of the liver x receptor alpha and methods of use
|
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
AU2008201044B2
(en)
*
|
2001-04-10 |
2011-07-28 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
PL370105A1
(en)
|
2001-05-25 |
2005-05-16 |
Amgen, Inc. |
B7 related protein-2 molecules and uses thereof
|
|
WO2003002737A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Riken |
Novel human topoisomerase 2α inhibitory protein and utilization thereof
|
|
AU2002321768B2
(en)
*
|
2001-07-26 |
2008-03-06 |
Serono Genetics Institute S.A. |
GMG-2 polynucleotides and polypeptides and uses thereof
|
|
US7888478B2
(en)
|
2002-09-11 |
2011-02-15 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US7858330B2
(en)
|
2001-10-19 |
2010-12-28 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US20040197778A1
(en)
*
|
2002-12-26 |
2004-10-07 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
|
US20030023042A1
(en)
*
|
2001-12-06 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2003050293A2
(en)
*
|
2001-12-07 |
2003-06-19 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
|
|
US7041499B2
(en)
*
|
2001-12-12 |
2006-05-09 |
University Of North Texas Health Science Center |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
|
|
AU2003241687A1
(en)
|
2002-05-31 |
2003-12-19 |
Amersham Biosciences K.K. |
Chondroitin synthetase and dna coding for the enzyme
|
|
WO2004032851A2
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Screening and therapeutic methods relating to neurogenesis
|
|
CA2500772A1
(en)
|
2002-10-07 |
2004-04-22 |
Zymogenetics, Inc. |
Uses of human zven antagonists
|
|
US20060281130A1
(en)
|
2002-12-20 |
2006-12-14 |
Elisabeth Bock |
Metod of modulation of interaction between receptor and ligand
|
|
WO2004078969A1
(en)
*
|
2003-03-06 |
2004-09-16 |
The New Industry Research Organization |
Identification and utilization of chondroitin polymerization factor
|
|
JP4912144B2
(en)
|
2003-03-12 |
2012-04-11 |
ジェネンテック， インコーポレイテッド |
Use of BV8 and / or EG-VEGF to promote hematopoiesis
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
JP4884224B2
(en)
*
|
2003-05-09 |
2012-02-29 |
ディアデクサス インコーポレーテッド |
Ovr110 antibody compositions and methods of use
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
US7964195B2
(en)
|
2005-01-07 |
2011-06-21 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
EP2384767B1
(en)
|
2005-03-24 |
2016-03-09 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind OV064 and methods of use therefor
|
|
BRPI0620601A2
(en)
|
2005-12-08 |
2011-11-16 |
Medarex Inc |
isolated human monoclonal antibody or antigen-binding portion thereof, composition, immunoconjugate, isolated nucleic acid molecule, expression vector, host cell, method for preparing an anti-o8e antibody and method for treating or preventing a disease defined by the growth of o8e expressing tumor cells
|
|
JP5391073B2
(en)
|
2006-11-27 |
2014-01-15 |
ディアデクサス インコーポレーテッド |
Ovr110 antibody compositions and methods of use
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
WO2008083239A2
(en)
|
2006-12-27 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for stimulating an immune response
|
|
EP2385114A4
(en)
|
2008-12-25 |
2012-08-08 |
Univ Tokyo |
Diagnosis of treatment of cancer using anti-tm4sf20 antibody
|
|
WO2011026122A2
(en)
|
2009-08-31 |
2011-03-03 |
Amplimmune, Inc. |
B7-h4 fusion proteins and methods of use thereof
|
|
KR20180100122A
(en)
|
2015-12-02 |
2018-09-07 |
주식회사 에스티사이언스 |
Antibodies specific for glycated BTLA (B- and T-lymphocyte weakening factor)
|
|
CN113214377B
(en)
*
|
2020-01-21 |
2022-10-28 |
四川大学 |
Antibacterial peptide AP-64 and preparation method and application thereof
|